(Version 1.2018, posted Oct. 3, 2017)
- Metastatic prostate cancer was added as an indication for evaluation and testing for the BRCA1 and BRCA2 genes
- Among BRCA1, BRCA2, TP53 and PTEN carriers, women between ages 25-29 may consider having an annual mammogram with consideration of tomosynthesis if a breast MRI is not available.
- Among female BRCA2 carriers, language regarding age of risk-reducing salpingo-oophorectomy (surgical removal of one or both ovaries and fallopian tubes) was updated to indicate that it may be delayed to age 40-45
- The table for other inherited breast and ovarian cancer genes was updated per the recent advances.
For the complete updated versions of the NCCN Guidelines, please visit NCCN.org